drugset / Trial / NCT00346177

Stem Cell Study for Patients With Heart Failure

NCT00346177

Phase 2 Withdrawn 30 enrolled Losordo, Douglas, M.D.
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine if cell therapy with your own cells (autologous cells) delivered with a catheter to regions of the heart with poor blood flow will be safe and if it will improve your ejection fraction and heart failure symptoms.

Timeline

Start
2010-09
Primary completion
2011-09
Completion
2012-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Autologous Stem Cells Cell therapy Other